Showing results (1521-1530 of 3,660) with videos related to
Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|October 29, 2020
Eligibility of real-world patients with metastatic breast cancer for clinical trialsAtul Batra, Shiying Kong, Winson Y CheungBreast (Edinburgh, Scotland)|September 12, 2022
Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysisYuting Sang, Benlong Yang, Miao Mo, et al.Breast (Edinburgh, Scotland)|September 12, 2022
A systematic review and meta-analysis of BRCA1/2 mutation for predicting the effect of platinum-based chemotherapy in triple-negative breast cancerXiaomeng Jia, Kainan Wang, Lingzhi Xu, et al.Breast (Edinburgh, Scotland)|November 27, 2021
Accelerating progress to innovation for patients: Trial design and risk stratificationMeredith M ReganBreast (Edinburgh, Scotland)|March 12, 2021
Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendationsNicola Rocco, Giuseppe Catanuto, Michela Cinquini, et al.Breast (Edinburgh, Scotland)|March 12, 2021
Long-term patient reported outcomes and hematologic toxicity among patients who received Granulocyte-Colony Stimulating Factors during chemotherapy for early breast cancerPietro Lapidari, Arnauld Gbenou, Julie Havas, et al.Breast (Edinburgh, Scotland)|December 17, 2021
BRCA1/2 testing for genetic susceptibility to cancer after 25 years: A scoping review and a primer on ethical implicationsDafina Petrova, Maite Cruz, María-José SánchezBreast (Edinburgh, Scotland)|December 19, 2021
Is sarcopenia a missed factor in the management of patients with metastatic breast cancer?Elise Deluche, Denis Lachatre, Mario Di Palma, et al.Breast (Edinburgh, Scotland)|January 8, 2022
Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planningIsabel T Rubio, Carolina SobridoBreast (Edinburgh, Scotland)|January 9, 2022
Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 studyAnthony J Maxwell, Bridget Hilton, Karen Clements, et al.Pageof 366